Attention-deficit hyperactivity disorder pathophysiology: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
 
(37 intermediate revisions by 6 users not shown)
Line 1: Line 1:
{{CMG}} {{AE}} {{CP}}
<div style="-webkit-user-select: none;">
{|class="infobox" style="position: fixed; top: 65%; right: 10px; margin: 0 0 0 0; border: 0; float: right;
|-
| {{#ev:youtube|https://https://www.youtube.com/watch?v=vQRh_VMA7Vc|350}}
|-
|}
{{CMG}}; {{AE}} {{CP}}, {{HW}}


{{ADHD}}
{{ADHD}}


==Overview==
==Overview==
Attention deficit hyperactivity disorder appears to be highly heritable, although one-fifth of all cases are estimated to be caused from [[trauma]] or [[toxic exposure]]. Evidence suggests that hyperactivity has a strong heritable component, and in all probability ADHD is a heterogeneous disorder, meaning that several causes could create very similar symptomology.<ref>{{cite web|url=http://www.continuingedcourses.net/active/courses/course003.php|title=Attention-Deficit/Hyperactivity Disorder: Nature, Course, Outcomes, and Comorbidity|last=Barkley|first=Russel A.|accessdate=2006-06-26}}</ref>. Although there is evidence for dopamine abnormalities in ADHD, it is not clear whether abnormalities of the [[dopamine]] system are the molecular abnormality of ADHD or a secondary consequence of a problem elsewhere.
ADHD appears to be highly [[heritable]], although one-fifth of all cases are caused by [[trauma]] or exposure to [[toxins]]. Evidence suggests that ADHD is a [[heterogeneous]] disorder, meaning that several causes could create very similar symptomology.<ref>{{cite web|url=http://www.continuingedcourses.net/active/courses/course003.php|title=Attention-Deficit/Hyperactivity Disorder: Nature, Course, Outcomes, and Comorbidity|last=Barkley|first=Russel A.|accessdate=2006-06-26}}</ref> Although there is evidence for dopamine abnormalities in ADHD, it is not clear whether abnormalities of the [[dopamine]] system are a molecular abnormality of ADHD or a secondary consequence of ADHD.


==Pathophysiology==
==Pathophysiology==
It is believed that there are several different causes of ADHD. Roughly 80 percent of ADHD is considered genetic in nature and the estimated contribution of non genetic factors to the contribution of all cases of ADHD is believed to be 20 percent.<ref>{{PDFlink|1=[http://www.schwablearning.org/pdfs/2200_7-barktran.pdf?date=4-12-05 Barkley presentaiton.]|2=779&nbsp;KiB<!-- application/pdf, 798631 bytes -->}} SchwabLearning.org.</ref>. Environmental agents also cause ADHD. These agents, such as alcohol, tobacco, and lead, are believed to stress babies prenatally and cause ADHD. Studies have found that malnutrition is also correlated with attention deficits. Diet seems to cause ADHD symptoms or make them worse. Many studies point to synthetic preservatives and artificial coloring agents aggravating ADD & ADHD symptoms in those affected.<ref>Food additives and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: a randomized, double-blinded, placebo-controlled trial”, Lancet, Sept 2007</ref><ref>1997 Graduate Student Research Project conducted at the University of South Florida. Author- Richard W. Pressinger M.Ed.</ref> Older studies were inconclusive quite possibly due to inadequate clinical methods of measuring offending behavior. Parental reports were more accurate indicators of the presence of additives than clinical tests.<ref>"Food Additives May Affect Kids' Hyperactivity", WebMD Medical News, May 24, 2004</ref>  Several major studies show academic performance increased and disciplinary problems decreased in large non-ADD student populations when artificial ingredients, including artificial colors were eliminated from school food programs.<ref>A different kind of school lunch", PURE FACTS October 2002</ref><ref>The Impact of a Low Food Additive and Sucrose Diet on Academic Performance in 803 New York City Public Schools, Schoenthaler SJ, Doraz WE, Wakefield JA, Int J Biosocial Res., 1986, 8(2); 185-195</ref>. Professor John Warner stated, “significant changes in children’s hyperactive behaviour could be produced by the removal of artificial colourings and [[sodium benzoate]] from their diet.” and “you could halve the number of kids suffering the worst behavioural problems by cutting out additives”.
===Pathogenesis===
 
*The exact pathogenesis of ADHD is not fully understood. It is believed that ADHD is caused by a complex interaction between genetic and environmental factors.<ref name="#15">M. T. Acosta, M. Arcos-Burgos, M. Muenke (2004). "Attention deficit/hyperactivity disorder (ADHD): Complex phenotype, simple genotype?". Genetics in Medicine 6 (1): 1–15.</ref> A [[meta-analysis]] of studies of functional and structural [[magnetic resonance imaging]] has identified several pathologies<ref name="pmid27276220">{{cite journal| author=Norman LJ, Carlisi C, Lukito S, Hart H, Mataix-Cols D, Radua J et al.| title=Structural and Functional Brain Abnormalities in Attention-Deficit/Hyperactivity Disorder and Obsessive-Compulsive Disorder: A Comparative Meta-analysis. | journal=JAMA Psychiatry | year= 2016 | volume= 73 | issue= 8 | pages= 815-825 | pmid=27276220 | doi=10.1001/jamapsychiatry.2016.0700 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27276220  }} </ref>.
In 1982, the NIH had determined, based on research available at that time, that roughly 5% of children with ADHD could be helped significantly by removing additives from their diet. The vast majority of these children were believed to have food allergies. <ref> http://www.nimh.nih.gov/health/publications/adhd/complete-publication.shtml#pub4'' </ref>
More recent studies have shown that approximately 60-70% of children with and without allergies improve when additives are removed from their diet,<ref name="Rowe94">
{{cite journal
| author=Rowe KS, Rowe KJ
| title=Synthetic food coloring and behavior: A dose response effect in a double-blind, placebo-controlled, repeated-measures study
| journal=Journal of Pediatrics
| year=1994
| volume=125
| pages=691&ndash;698
| id =7965420}}
</ref>  that up to almost 90% of them react when an appropriate amount of additive is used as a challenge in double blind tests,<ref name="Pollock90">
{{cite journal
| author = Pollock, I. and Warner, J.O.
| year = 1990
| month = January
| title = Effect of artificial food colours on childhood behaviour
| journal = Arch Dis Child
| volume = 65
| issue = 1
| pages = 74-77
| id = PMID 2301986
}}</ref> and that food additives may elicit hyperactive behavior and/or irritability in normal children as well.<ref name="McCann">
{{cite journal
| author = McCann D, Barrett A, Cooper A, Crumpler D, Dalen L, Grimshaw K, Kitchin E, Lok K, Porteous L, Prince E, Sonuga-Barke E, Warner JO, Stevenson J.
| year = 2007 Nov
| title = Food additives and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: a randomised, double-blinded, placebo-controlled trial.
| journal = Lancet.
| volume = 3;370(9598)
| pages = 1560-7
| id = PMID 17825405
}}</ref>


===Genetics===
===Genetics===
According to a majority of medical research in the United States, as well as other countries, ADHD is today generally regarded as a chronic disorder for which there are some effective treatments, but no true cure.<ref>[http://www.ninds.nih.gov/disorders/adhd/adhd.htm NINDS Attention Deficit-Hyperactivity Disorder Information Page.] National Institute of Neurological Disorders and Stroke (NINDS/NIH) February 9, 2007. Retrieved on 2007-08-13.</ref> Evidence suggests that hyperactivity has a strong heritable component, and in all probability ADHD is a heterogeneous disorder, meaning that several causes could create very similar symptomology.<ref>{{cite web|url=http://www.continuingedcourses.net/active/courses/course003.php|title=Attention-Deficit/Hyperactivity Disorder: Nature, Course, Outcomes, and Comorbidity|last=Barkley|first=Russel A.|accessdate=2006-06-26}}</ref> Candidate genes include [[dopamine transporter]] (DAT), [[dopamine receptor]] D4 (DRD4), [[dopamine beta-hydroxylase]] (DBH), [[monoamine oxidase]] A (MAOA), [[catecholamine]]-methyl transferase (COMT), serotonin transporter promoter (SLC6A4), 5-hydroxytryptamine 2A receptor (5-HT2A), and 5-hydroxytryptamine 1B receptor (5-HT1B). Researchers believe that a large majority of ADHD arises from a combination of various genes, many of which affect [[dopamine]] transporters.<ref name="dopamine">Roman T, Rohde LA, Hutz MH. (2004). "Polymorphisms of the dopamine transporter gene: influence on response to methylphenidate in attention deficit-hyperactivity disorder." ''American Journal of Pharmacogenomics'' 4(2):83–92 PMID 15059031 </ref>  Suspect genes include the 10-repeat allele of the DAT1 gene,<ref name="gene">Swanson JM, Flodman P, Kennedy J, et al. "Dopamine Genes and ADHD." ''Neurosci Biobehav Rev.'' 2000 Jan;24(1):21–5. PMID 10654656</ref> the 7-repeat allele of the DRD4 gene,<ref name="gene"/> and the dopamine beta hydroxylase gene (DBH TaqI).<ref>Smith KM, Daly M, Fischer M, et al. "Association of the dopamine beta hydroxylase gene with attention deficit hyperactivity disorder: genetic analysis of the Milwaukee longitudinal study." ''Am J Med Genet B Neuropsychiatr Genet.'' 2003 May 15;119(1):77–85. PMID 12707943</ref>
*Common genetic variation accounts for around 75% of cases of ADHD.<ref name="#6"></ref> [[Loci]] on [[chromosomes]] 7, 11, 12, 15, 16, and 17 are associated with ADHD, likely indicating that ADHD does not follow the traditional model of an [[hereditary disease]].<ref name="#15">M. T. Acosta, M. Arcos-Burgos, M. Muenke (2004). "Attention deficit/hyperactivity disorder (ADHD): Complex phenotype, simple genotype?". Genetics in Medicine 6 (1): 1–15.</ref>


Genome wide surveys have shown linkage between ADHD and loci on chromosomes 7, 11, 12, 15, 16, and 17.<ref>{{cite journal | author=M. T. Acosta, M. Arcos-Burgos, M. Muenke | title=Attention deficit/hyperactivity disorder (ADHD): Complex phenotype, simple genotype? | journal=Genetics in Medicine | year=2004 | volume=6 | issue=1 | pages= 1–15}}</ref> If anything, the broad selection of targets indicates the likelihood that ADHD does not follow the traditional model of a "genetic disease" and is better viewed as a complex interaction among genetic and environmental factors. As the authors of a review of the question have noted, "Although several genome-wide searches have identified chromosomal regions that are predicted to contain genes that contribute to ADHD susceptibility, to date no single gene with a major contribution to ADHD has been identified."<ref>{{cite journal | author=M. T. Acosta, M. Arcos-Burgos, M. Muenke | title=Attention deficit/hyperactivity disorder (ADHD): Complex phenotype, simple genotype? | journal=Genetics in Medicine | year=2004 | volume=6 | issue=1 | pages= 1–15}}</ref>
*[[Norepinephrine]] and [[dopamine]] play a critical role in modulating [[attention]] in ADHD patients. Norepinephrine seems to have more of an effect on [[executive function]], whereas dopamine may be more important in maintaining attention. A variety of [[dopamine]] and [[serotonin]] receptors (e.g., dopamine 4 and 5, serotonin 1B) are associated with ADHD.<ref name="#7">Briars, L., & Todd, T. (2016). A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder. The Journal of Pediatric Pharmacology and Therapeutics : JPPT, 21(3), 192–206. http://doi.org/10.5863/1551-6776-21.3.192</ref>


Studies show that there is a familial transmission of the disorder which does not occur through adoptive relationships.<ref name="BarkleyContEd">Barkley, Russell A. [http://www.continuingedcourses.net/active/courses/course003.php Attention-Deficit/Hyperactivity Disorder: Nature, Course, Outcomes, and Comorbidity.] ContinuinedEdCourse.Net.  Retrieved on [[2007-08-12]].</ref> [[Twin study|Twin studies]] indicate that the disorder is highly heritable and that genetics contribute about three quarters of the total ADHD population.<ref name="BarkleyContEd"/> While the majority of ADHD is believed to be genetic in nature,<ref name="BarkleyContEd"/> roughly one-fifth of all ADHD cases are thought to be acquired after conception due to [[Traumatic brain injury|brain injury]] caused by either toxins or physical trauma prenatally or postnatally.<ref name="BarkleyContEd"/>
*Mutations in the PTCHD1 gene, which is active in the [[thalamus]], are associated with [[attention deficit]], [[hyperactivity]], and [[learning disability]]. Lack of a functional copy of the gene in the [[thalamic reticular nucleus]] (TRN) results in [[attention deficit]], [[hyperactivity]], and disrupted sleep.<ref name="#5">M. F. Wells, R. D. Wimmer, L. I. Schmitt, G. Feng, M. M. Halassa. (2016). "Thalamic reticular impairment underlies attention deficit in Ptchd1Y/− mice." Nature 532: 58-63.</ref>


===Non-Genetic Factors===
===Dopamine Levels and Blood Circulation===
The estimated contribution of non genetic factors to the contribution of all cases of ADHD is 20 percent.<ref>{{PDFlink|1=[http://www.schwablearning.org/pdfs/2200_7-barktran.pdf?date=4-12-05 Barkley presentaiton.]|2=779&nbsp;[[Kibibyte|KiB]]<!-- application/pdf, 798631 bytes -->}} SchwabLearning.org.</ref> The environmental factors implicated are common exposures and include alcohol, ''in utero'' tobacco smoke and lead exposure. Lead concentration below the [[Center for Disease Control]]'s [[action level]] account for slightly more cases of ADHD than tobacco smoke (290 000 versus 270 000, in the USA, ages 4 to 15).<ref name="pmid17185283">{{cite journal |author=Braun JM, Kahn RS, Froehlich T, Auinger P, Lanphear BP |title=Exposures to environmental toxicants and attention deficit hyperactivity disorder in U.S. children |journal=Environ. Health Perspect. |volume=114 |issue=12 |pages=1904–9 |year=2006 |pmid=17185283}}: "''Compared with the lowest quintile of blood lead levels, children with blood lead levels > 2.0 µg/dL were at a '''4.1-fold increased risk of ADHD'''. When we limited the analysis to children with blood lead levels ≤ 5 µg/dL, the association between increased blood lead levels and ADHD remained. These results are consistent with previous reports that have found significant associations between blood or dentin lead levels and behavior problems .... Our results further indicate that blood lead levels below the CDC action level of 10 µg/dL are associated with an increased risk for ADHD in children. This result is consistent with previous studies that have found cognitive deficits in children with blood lead levels < 10 µg/dL.''"</ref> Complications during pregnancy and birth&mdash;including [[premature birth]]&mdash;might also play a role. It has been observed that women who smoke while pregnant are more likely to have children with ADHD.<ref>Kotimaa AJ, Moilanen I, Taanila A, et al. ,"Maternal smoking and hyperactivity in 8-year-old children". 2003,  ''J Am Acad Child Adol Psychiatry'' Jul;42(7):826–33. PMID 12819442</ref>  This could be related to the fact that nicotine is known to cause [[Hypoxia (medical)|hypoxia]] (lack of oxygen) ''in utero'', but it could also be that ADHD women have more probabilities to smoke both in general and during pregnancy, being more likely to have children with ADHD due to genetic factors.


===Dopamine Levels and Blood Circulation===
*ADHD patients have reduced [[blood circulation]]<ref>Lou HC, Andresen J, Steinberg B, McLaughlin T, Friberg L. "The striatum in a putative cerebral network activated by verbal awareness in normals and in ADHD children." ''Eur J Neurol.'' 1998 Jan;5(1):67–74. PMID 10210814</ref> and a significantly higher concentration of [[dopamine]] transporters in the [[striatum]], a part of the brain that plays a role in [[executive function]].<ref>{{cite journal |author=Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras BK, Fischman AJ |title=Dopamine transporter density in patients with attention deficit hyperactivity disorder |journal=Lancet |volume=354 |issue=9196 |pages=2132–-33 |year=1999 |pmid=10609822}}</ref><ref>{{cite journal |author=Dresel SH, Kung MP, Plössl K, Meegalla SK, Kung HF |title=Pharmacological effects of dopaminergic drugs on in vivo binding of [99mTc]TRODAT-1 to the central dopamine transporters in rats |journal=European journal of nuclear medicine |volume=25 |issue=1 |pages=31–9 |year=1998 |pmid=9396872}}</ref>
[[SPECT]] scans found people with ADHD to have reduced blood circulation,<ref>Lou HC, Andresen J, Steinberg B, McLaughlin T, Friberg L. "The striatum in a putative cerebral network activated by verbal awareness in normals and in ADHD children." ''Eur J Neurol.'' 1998 Jan;5(1):67–74. PMID 10210814</ref> and a significantly higher concentration of dopamine transporters in the [[striatum]] which is in charge of planning ahead.<ref>{{cite journal |author=Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras BK, Fischman AJ |title=Dopamine transporter density in patients with attention deficit hyperactivity disorder |journal=Lancet |volume=354 |issue=9196 |pages=2132–-33 |year=1999 |pmid=10609822}}</ref><ref>{{cite journal |author=Dresel SH, Kung MP, Plössl K, Meegalla SK, Kung HF |title=Pharmacological effects of dopaminergic drugs on in vivo binding of [99mTc]TRODAT-1 to the central dopamine transporters in rats |journal=European journal of nuclear medicine |volume=25 |issue=1 |pages=31–9 |year=1998 |pmid=9396872}}</ref> A study by the U.S. Department of Energy’s [[Brookhaven National Laboratory]] in collaboration with [[Mount Sinai School of Medicine]] in New York suggest that it is not the dopamine transporter levels that indicate ADHD, but the brain's ability to produce dopamine itself. The study was done by injecting 20 ADHD subjects and 25 control subjects with a radiotracer that attaches itself to dopamine transporters. The study found that it was not the transporter levels that indicated ADHD, but the dopamine itself. ADHD subjects showed lower levels of dopamine across the board. They speculated that since ADHD subjects had lower levels of dopamine to begin with, the number of transporters in the brain was not the telling factor. In support of this notion, plasma [[homovanillic acid]], an index of dopamine levels, was found to be inversely related not only to childhood ADHD symptoms in adult psychiatric patients, but to "childhood learning problems" in healthy subjects as well.<ref name="pmid17113158">{{cite journal |author=Coccaro EF, Hirsch SL, Stein MA |title=Plasma homovanillic acid correlates inversely with history of learning problems in healthy volunteer and personality disordered subjects |journal=Psychiatry research |volume=149 |issue=1–3 |pages=297–302 |year=2007 |pmid=17113158 |doi=10.1016/j.psychres.2006.05.009}}</ref>


Although there is evidence for dopamine abnormalities in ADHD, it is not clear whether abnormalities of the dopamine system are the molecular abnormality of ADHD or a secondary consequence of a problem elsewhere. Researchers have described [[Hypokalemic sensory overstimulation|a form of ADHD]] in which the abnormality appears to be sensory overstimulation resulting from a disorder of ion channels in the peripheral nervous system.
*It is likely not the dopamine transporter levels that indicate the presence of ADHD, but the brain's ability to produce dopamine itself. ADHD patients show lower levels of dopamine than healthy subjects across the board. Further, plasma [[homovanillic acid]], an index of [[dopamine]] levels, is inversely related not only to childhood ADHD symptoms in adult psychiatric patients, but to "childhood learning problems" in healthy subjects as well.<ref name="pmid17113158">{{cite journal |author=Coccaro EF, Hirsch SL, Stein MA |title=Plasma homovanillic acid correlates inversely with history of learning problems in healthy volunteer and personality disordered subjects |journal=Psychiatry research |volume=149 |issue=1–3 |pages=297–302 |year=2007 |pmid=17113158 |doi=10.1016/j.psychres.2006.05.009}}</ref>


===Glucose Metabolism===
===Glucose Metabolism===
An early [[Positron emission tomography|PET scan]] study found that global cerebral [[glucose catabolism|glucose metabolism]] was 8.1% lower in medication-naive adults who had been diagnosed as ADHD while children. The image on the left illustrates glucose metabolism in the brain of a 'normal' adult while doing an assigned auditory attention task; the image on the right illustrates the areas of activity in the brain of an adult who had been diagnosed with ADHD as a child when given that same task; these are not pictures of individual brains, which would contain substantial overlap, these are images constructed to illustrate group-level differences. Additionally, the regions with the greatest deficit of activity in the ADHD patients (relative to the controls) included the [[premotor cortex]] and the superior [[prefrontal cortex]].<ref name="Zametkin"/> A second study in adolescents failed to find statistically significant differences in global glucose metabolism between ADHD patients and controls, but did find statistically significant deficits in 6 specific regions of the brains of the ADHD patients (relative to the controls).  Most notably, lower metabolic activity in one specific region of the left anterior [[frontal lobe]] was significantly inversely correlated with symptom severity.<ref>Zametkin AJ, Liebenauer LL, Fitzgerald GA,, et al. "Brain metabolism in teenagers with attention-deficit hyperactivity disorder." ''Arch Gen Psychiatry.''. 1993 May 50;333(5). PMID 2233902</ref>  These findings strongly imply that lowered activity in specific regions of the brain, rather than a broad global deficit, is involved in ADHD symptoms.  However, these readings are of subjects doing an ''assigned task.'' They could be found in ADHD diagnosed patients because they simply were not attending to the task.  Hence the parts of the brain used by others doing the task would not show equal activity in the ADHD patients.
*An early [[Positron emission tomography|PET scan]] study found that global cerebral [[glucose catabolism|glucose metabolism]] was 8.1% lower in medication-naive adults who had been diagnosed as ADHD while children. The image on the left illustrates glucose metabolism in the brain of a "normal" adult while doing an assigned auditory attention task; the image on the right illustrates the areas of activity in the brain of an adult who had been diagnosed with ADHD as a child when given that same task. (These are not pictures of individual brains, which would contain substantial overlap, but rather images constructed to illustrate group-level differences.)
*Additionally, the regions with the greatest deficit of activity in the ADHD patients (relative to the controls) included the [[premotor cortex]] and the superior [[prefrontal cortex]].<ref name="Zametkin"/> ADHD symptoms are likely the result of impaired activity in specific regions of the brain, rather than a broad, global deficit.
[[Image:Adhdbrain.gif|180px|framed|center|PET scans of glucose metabolism in the brains of a normal adult (left) compared to an adult diagnosed with ADHD (right).<ref name="Zametkin">Zametkin AJ, Nordahl TE, Gross M, et al. "Cerebral glucose metabolism in adults with hyperactivity of childhood onset." ''N Engl J Med''. 1990 November 15;323(20):1361–6. PMID 2233902</ref> "This PET scan was taken from Zametkin's landmark 1990 study, which found lower glucose metabolism, in the brains of patients with ADHD who had never taken medication. Scans were taken while patients were engaging in tasks requiring focused attention. The greatest deficits were found in the premotor cortex and superior prefrontal cortex."]]
[[Image:Adhdbrain.gif|180px|framed|center|PET scans of glucose metabolism in the brains of a normal adult (left) compared to an adult diagnosed with ADHD (right).<ref name="Zametkin">Zametkin AJ, Nordahl TE, Gross M, et al. "Cerebral glucose metabolism in adults with hyperactivity of childhood onset." ''N Engl J Med''. 1990 November 15;323(20):1361–6. PMID 2233902</ref> "This PET scan was taken from Zametkin's landmark 1990 study, which found lower glucose metabolism, in the brains of patients with ADHD who had never taken medication. Scans were taken while patients were engaging in tasks requiring focused attention. The greatest deficits were found in the premotor cortex and superior prefrontal cortex."]]


===Head Injuries===
===Associated Conditions===
Head injuries can cause a person to present ADHD-like symptoms,<ref>McAvinue L, O'Keeffe F, McMackin D, Robertson IH, et al. "Impaired sustained attention and error awareness in traumatic brain injury: implications for insight"  ''Neuropsychological Rehabilitation''. 2005 Dec;15(5):569–87. PMID 16381141</ref> possibly because of damage done to the patient's frontal lobes. Because these types of symptoms can be attributable to brain damage, one earlier designation for ADHD was "Minimal Brain Damage".<ref>[http://www.add.org/articles/causeadd.html What Causes ADD.] Attention Deficit Disorder Association. Retrieved on 2007-08-13.</ref>
*ADHD is associated with many of the same inherited genetic variations as [[clinical depression]].<ref name="#6">Cross-Disorder Group of the Psychiatric Genomics Consortium. "Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs." Nat Genet. (2013). 45(9):984-94. doi: 10.1038/ng.2711. Epub 2013 Aug 11.</ref> Other conditions, such as [[learning disabilities]], [[anxiety disorder]], [[conduct disorder]], [[depression]], and [[substance abuse]], are common in people with ADHD.<ref name="#1">National Institute of Mental Health (NIH). (2016). "Attention Deficit Hyperactivity Disorder."</ref>
 
===Social Causes===
There is no compelling evidence that social factors alone can create ADHD.<ref name="BarkleyContEd"/> Many researchers believe that attachments and relationships with caregivers and other features of a child's environment have profound effects on attentional and self-regulatory capacities. It is noteworthy that a study of foster children found that an inordinate number of them had symptoms closely resembling ADHD.<ref>{{PDFlink|[http://www.vera.org/publication_pdf/169_280.pdf What Keeps Children in Foster Care from Succeeding in School.]|661&nbsp;KiB<!-- application/pdf, 677488 bytes -->}}</ref> An editorial in a special edition of [[Clinical Psychology]] in 2004 stated that "our impression from spending time with young people, their families and indeed colleagues from other disciplines is that a medical diagnosis and medication is not enough. In our clinical experience, without exception, we are finding that the same conduct typically labelled ADHD is shown by children in the context of violence and abuse, impaired parental attachments and other experiences of emotional trauma."<ref>Adam James (2004) [http://www.psychminded.co.uk/news/news2004/august04/Clinical%20psychology%20publishes%20critique%20of%20ADHD%20diagnosis%20and%20use%20of%20medication%20on%20children.htm  ''Clinical psychology publishes critique of ADHD diagnosis and use of medication on children''] published on Psychminded.co.uk Psychminded Ltd</ref> Furthermore, [[Complex Post Traumatic Stress Disorder]] can result in attention problems that can look like ADHD, as can [[Sensory Integration Dysfunction|Sensory Integration Disorders]].


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
{{WH}}
{{WS}}
[[Category:Psychiatry]]
[[Category:Pediatrics]]

Latest revision as of 15:25, 14 January 2019

https://https://www.youtube.com/watch?v=vQRh_VMA7Vc%7C350}}

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Charmaine Patel, M.D. [2], Haleigh Williams, B.S.

Attention-deficit hyperactivity disorder Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Attention-Deficit Hyperactivity Disorder from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Psychiatric Examination

Laboratory Findings

Imaging Findings

Treatment

Medical Therapy

Psychotherapy

Brain Stimulation Therapy

Cost-Effectiveness of Therapy

Monitoring Response to Therapy

Future or Investigational Therapies

Case Studies

Case #1

Template:Attention-deficit hyperactivity disorder On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Attention-deficit hyperactivity disorder pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Attention-deficit hyperactivity disorder pathophysiology

CDC on Attention-deficit hyperactivity disorder pathophysiology

Attention-deficit hyperactivity disorder pathophysiology in the news

Blogs on Attention-deficit hyperactivity disorder pathophysiology

Directions to Hospitals Treating Attention-deficit hyperactivity disorder

Risk calculators and risk factors for Attention-deficit hyperactivity disorder pathophysiology

Overview

ADHD appears to be highly heritable, although one-fifth of all cases are caused by trauma or exposure to toxins. Evidence suggests that ADHD is a heterogeneous disorder, meaning that several causes could create very similar symptomology.[1] Although there is evidence for dopamine abnormalities in ADHD, it is not clear whether abnormalities of the dopamine system are a molecular abnormality of ADHD or a secondary consequence of ADHD.

Pathophysiology

Pathogenesis

  • The exact pathogenesis of ADHD is not fully understood. It is believed that ADHD is caused by a complex interaction between genetic and environmental factors.[2] A meta-analysis of studies of functional and structural magnetic resonance imaging has identified several pathologies[3].

Genetics

  • Common genetic variation accounts for around 75% of cases of ADHD.[4] Loci on chromosomes 7, 11, 12, 15, 16, and 17 are associated with ADHD, likely indicating that ADHD does not follow the traditional model of an hereditary disease.[2]

Dopamine Levels and Blood Circulation

  • It is likely not the dopamine transporter levels that indicate the presence of ADHD, but the brain's ability to produce dopamine itself. ADHD patients show lower levels of dopamine than healthy subjects across the board. Further, plasma homovanillic acid, an index of dopamine levels, is inversely related not only to childhood ADHD symptoms in adult psychiatric patients, but to "childhood learning problems" in healthy subjects as well.[10]

Glucose Metabolism

  • An early PET scan study found that global cerebral glucose metabolism was 8.1% lower in medication-naive adults who had been diagnosed as ADHD while children. The image on the left illustrates glucose metabolism in the brain of a "normal" adult while doing an assigned auditory attention task; the image on the right illustrates the areas of activity in the brain of an adult who had been diagnosed with ADHD as a child when given that same task. (These are not pictures of individual brains, which would contain substantial overlap, but rather images constructed to illustrate group-level differences.)
  • Additionally, the regions with the greatest deficit of activity in the ADHD patients (relative to the controls) included the premotor cortex and the superior prefrontal cortex.[11] ADHD symptoms are likely the result of impaired activity in specific regions of the brain, rather than a broad, global deficit.
PET scans of glucose metabolism in the brains of a normal adult (left) compared to an adult diagnosed with ADHD (right).[11] "This PET scan was taken from Zametkin's landmark 1990 study, which found lower glucose metabolism, in the brains of patients with ADHD who had never taken medication. Scans were taken while patients were engaging in tasks requiring focused attention. The greatest deficits were found in the premotor cortex and superior prefrontal cortex."

Associated Conditions

References

  1. ↑ Barkley, Russel A. "Attention-Deficit/Hyperactivity Disorder: Nature, Course, Outcomes, and Comorbidity". Retrieved 2006-06-26.
  2. ↑ 2.0 2.1 M. T. Acosta, M. Arcos-Burgos, M. Muenke (2004). "Attention deficit/hyperactivity disorder (ADHD): Complex phenotype, simple genotype?". Genetics in Medicine 6 (1): 1–15.
  3. ↑ Norman LJ, Carlisi C, Lukito S, Hart H, Mataix-Cols D, Radua J; et al. (2016). "Structural and Functional Brain Abnormalities in Attention-Deficit/Hyperactivity Disorder and Obsessive-Compulsive Disorder: A Comparative Meta-analysis". JAMA Psychiatry. 73 (8): 815–825. doi:10.1001/jamapsychiatry.2016.0700. PMID 27276220.
  4. ↑ 4.0 4.1 Cross-Disorder Group of the Psychiatric Genomics Consortium. "Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs." Nat Genet. (2013). 45(9):984-94. doi: 10.1038/ng.2711. Epub 2013 Aug 11.
  5. ↑ Briars, L., & Todd, T. (2016). A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder. The Journal of Pediatric Pharmacology and Therapeutics : JPPT, 21(3), 192–206. http://doi.org/10.5863/1551-6776-21.3.192
  6. ↑ M. F. Wells, R. D. Wimmer, L. I. Schmitt, G. Feng, M. M. Halassa. (2016). "Thalamic reticular impairment underlies attention deficit in Ptchd1Y/− mice." Nature 532: 58-63.
  7. ↑ Lou HC, Andresen J, Steinberg B, McLaughlin T, Friberg L. "The striatum in a putative cerebral network activated by verbal awareness in normals and in ADHD children." Eur J Neurol. 1998 Jan;5(1):67–74. PMID 10210814
  8. ↑ Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras BK, Fischman AJ (1999). "Dopamine transporter density in patients with attention deficit hyperactivity disorder". Lancet. 354 (9196): 2132–-33. PMID 10609822.
  9. ↑ Dresel SH, Kung MP, Plössl K, Meegalla SK, Kung HF (1998). "Pharmacological effects of dopaminergic drugs on in vivo binding of [99mTc]TRODAT-1 to the central dopamine transporters in rats". European journal of nuclear medicine. 25 (1): 31–9. PMID 9396872.
  10. ↑ Coccaro EF, Hirsch SL, Stein MA (2007). "Plasma homovanillic acid correlates inversely with history of learning problems in healthy volunteer and personality disordered subjects". Psychiatry research. 149 (1–3): 297–302. doi:10.1016/j.psychres.2006.05.009. PMID 17113158.
  11. ↑ 11.0 11.1 Zametkin AJ, Nordahl TE, Gross M, et al. "Cerebral glucose metabolism in adults with hyperactivity of childhood onset." N Engl J Med. 1990 November 15;323(20):1361–6. PMID 2233902
  12. ↑ National Institute of Mental Health (NIH). (2016). "Attention Deficit Hyperactivity Disorder."

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Attention-deficit_hyperactivity_disorder_pathophysiology&oldid=1535400"